About US
Contact us
-
China shuts down 10 drug capsulemakersShut them down. That is what China's top drug regulator told state authorities to do to any manufacturer whose drug capsules are found to have unacceptable levels of chromium. Enforcement authorities2012/4/23
-
NIFDC Strategic Advisory Expert Committee and the Eighth Academic Committee establishedOn April 16, 2012, the inaugurating meeting for the Strategic Advisory Expert Committee and the Eighth Academic Committee of the National Institutes for Food and Drug Control (NIFDC) was held in Beiji2012/4/23
-
HGS snubs $2.6B buyout offer from Benlysta partner GSKHuman Genome Sciences ($HGSI) is entertaining bids after rebuffing partner GlaxoSmithKline's ($GSK) $2.59 billion buyout overture, thinking that its pipeline of antibody drugs and its Benlysta busines2012/4/20
-
Roche acne drug linked to eye problemsAn Israel-based team of researchers has found an uptick in eye ailments in teens and young adults taking the anti-acne med isotretinoin, sold by Swiss drug giant Roche ($RHHBY) under the brand name Ro2012/4/20
-
Roche decides to fold up its tent when Illumina offer expiresRoche ($RHHBY) said it wouldn't extend its $51-per-share bid for Illumina, after voting tallies indicated that shareholders backed the gene-sequencing company's incumbent board candidates, rather than2012/4/19
-
WSJ: Pfizer poised to sell nutrition biz to Nestlé for $9B-plusIt looks as if Nestlé has prevailed in the bidding for Pfizer's nutrition unit. Sources tell The Wall Street Journal that the Swiss food company is close to snapping up the business for at least $92012/4/19
-
Chinese regulators freeze sales of drugs with toxic capsulesAnother scandal is roiling China's burgeoning pharma industry. The country's drug watchdog has banned the sale of 13 drugs that include traditional Chinese meds and antibiotics that are made with c2012/4/18
-
Supreme Court zeroes in on pharma reps' OT claimsWill pharma reps' crusade for overtime pay survive the U.S. Supreme Court? Hearing arguments in a key case yesterday, some of the justices seemed skeptical of the very idea. And at least one was cl2012/4/18
-
Justice, J&J duel over Gorsky's contribution to kickback caseAlex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step into the role of CEO at the healthcare giant Johnson & Johnson ($JNJ).2012/4/17
-
S. Africa ratchets up protection for domestic drugmakersWarning to pharma companies aiming to sell key drugs in South Africa: Only domestic drugmakers need apply. The government is putting together a list of 70-plus medications that will have to be proc2012/4/17